Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Atossa Therapeutics Inc (NASDAQ: ATOS) was $0.84 for the day, down -6.11% from the previous closing price of $0.90. In other words, the price has decreased by -$6.11 from its previous closing price. On the day, 0.91 million shares were traded. ATOS stock price reached its highest trading level at $0.9265 during the session, while it also had its lowest trading level at $0.8411.
Ratios:
Our analysis of ATOS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.99 and its Current Ratio is at 14.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 26 ’25 when Remmel H. Lawrence bought 10,000 shares for $0.70 per share. The transaction valued at 7,000 led to the insider holds 10,257 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 108890312 and an Enterprise Value of 37806312.
Stock Price History:
The Beta on a monthly basis for ATOS is 1.02, which has changed by -0.49397588 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, ATOS has reached a high of $1.81, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is 18.28%, while the 200-Day Moving Average is calculated to be -23.66%.
Shares Statistics:
ATOS traded an average of 622.54K shares per day over the past three months and 696680 shares per day over the past ten days. A total of 129.17M shares are outstanding, with a floating share count of 129.13M. Insiders hold about 0.03% of the company’s shares, while institutions hold 27.62% stake in the company. Shares short for ATOS as of 1744675200 were 7627038 with a Short Ratio of 12.25, compared to 1741910400 on 8580955. Therefore, it implies a Short% of Shares Outstanding of 7627038 and a Short% of Float of 5.91.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A comprehensive evaluation of Atossa Therapeutics Inc (ATOS) is underway, with the input of 2.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.06 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.25 and -$0.25 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$0.28, with 3.0 analysts recommending between -$0.25 and -$0.3.
